Company Profile

Qutoutiao Inc (NASDAQ: QTT)
Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -31.11
% Price Change (last 13 weeks): -17.88
% Price Change (last 26 weeks): 66.22
% Price Change (last 52 weeks): 18.66
% Price Change (year to date): 64.93
Management Effectiveness
Return on Equity (%): -90.02
Return on Assets (%): -42.26
Return on Invested Capital (%): -46.41
Profitability
Gross Profit Margin (%): 50.00
Net Profit Margin (%): -9771.71
Operating Profit Margin (%): -7967.30
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.
Qutoutiao Inc
830 Winter Street 2nd floor
Waltham MA 02451

Phone: n/a
Fax: n/a
http://www.q32bio.com
Per Share Data
Earnings (1year) ($): -35.16
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 22.65
Cash Flow ($): -34.87
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 30.42
Price/Book (x): 0.48
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 7.25
Current Ratio (x): 7.25
LT Debt/Equity (x): 0.00
Total Debt/Equity (x): 1.81



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.